Correction: HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway.
作者信息
Liang Yunan, Lin Han, Jiang Zongsheng, Zhao Qi, Cui Ri, Li Shaotang
机构信息
Department of Colorectal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang Street, Ouhai District, Wenzhou, 325000, Zhejiang, China.
Cancer and Anticancer Drug Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Chashan Road, Wenzhou, 325035, Zhejiang, China.
出版信息
Discov Oncol. 2025 Jan 30;16(1):103. doi: 10.1007/s12672-024-01512-0.
Abstract
摘要
相似文献
1
Correction: HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway.更正：HOXB8通过激活STAT3通路介导大肠癌细胞对西妥昔单抗的耐药性。
Discov Oncol. 2025 Jan 30;16(1):103. doi: 10.1007/s12672-024-01512-0.
2
HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway.HOXB8通过激活STAT3信号通路介导大肠癌细胞对西妥昔单抗的耐药性。
Discov Oncol. 2024 Oct 29;15(1):603. doi: 10.1007/s12672-024-01440-z.
3
HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation.HOXB8通过激活STAT3促进上皮-间质转化，从而增强结肠癌细胞的增殖和转移。
Cancer Cell Int. 2019 Jan 3;19:3. doi: 10.1186/s12935-018-0717-6. eCollection 2019.
4
The roles of HOXB8 through activating Wnt/β-catenin and STAT3 signaling pathways in the growth, migration and invasion of ovarian cancer cells.HOXB8通过激活Wnt/β-连环蛋白和STAT3信号通路在卵巢癌细胞生长、迁移和侵袭中的作用。
Cytotechnology. 2022 Feb;74(1):77-87. doi: 10.1007/s10616-021-00508-w. Epub 2022 Jan 3.
5
Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer.Sonic 刺猬通路的激活与结直肠癌中西妥昔单抗耐药和 EphB3 受体诱导有关。
Theranostics. 2019 Apr 12;9(8):2235-2251. doi: 10.7150/thno.30678. eCollection 2019.
6
Knock-Down of HOXB8 Prohibits Proliferation and Migration of Colorectal Cancer Cells via Wnt/β-Catenin Signaling Pathway.HOXB8 敲低通过 Wnt/β-连环蛋白信号通路抑制结直肠癌细胞的增殖和迁移。
Med Sci Monit. 2019 Jan 24;25:711-720. doi: 10.12659/MSM.912218.
7
Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition.结直肠癌细胞对抗 EGFR 抗体的原发和获得性耐药都集中在 MEK/ERK 通路的激活上，联合 MEK/EGFR 抑制可以克服这种耐药性。
Clin Cancer Res. 2014 Jul 15;20(14):3775-86. doi: 10.1158/1078-0432.CCR-13-2181. Epub 2014 May 8.
8
Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity.抗表皮生长因子受体（EGFR）治疗效果与信号转导和转录激活因子3（STAT3）活性的抑制直接相关。
Cancer Biol Ther. 2014 May;15(5):623-32. doi: 10.4161/cbt.28179. Epub 2014 Feb 20.
9
Exosome-derived lnc-HOXB8-1:2 induces tumor-associated macrophage infiltration to promote neuroendocrine differentiated colorectal cancer progression by sponging hsa-miR-6825-5p.外泌体来源的长链非编码 RNA-HOXB8-1:2 通过海绵吸附 hsa-miR-6825-5p 诱导肿瘤相关巨噬细胞浸润促进神经内分泌分化结直肠癌细胞的进展。
BMC Cancer. 2022 Aug 27;22(1):928. doi: 10.1186/s12885-022-09926-1.
10
Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.靶向 Stat3 可消除癌症中 EGFR 抑制剂耐药性。
Clin Cancer Res. 2012 Sep 15;18(18):4986-96. doi: 10.1158/1078-0432.CCR-12-0792. Epub 2012 Jul 23.
本文引用的文献
1
HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway.HOXB8通过激活STAT3信号通路介导大肠癌细胞对西妥昔单抗的耐药性。
Discov Oncol. 2024 Oct 29;15(1):603. doi: 10.1007/s12672-024-01440-z.
Zotero 插件